Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options

Sarah J. Chalmers, Mark Wylam

Research output: Contribution to journalArticle

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infection worldwide, including a wide array of both hospital- and community-acquired infections-most commonly bacteremia, upper and lower respiratory tract infection, skin and soft-tissue infection, osteomyelitis, and septic arthritis. This chapter describes the epidemiology of MRSA infection, its ability to confer antibiotic resistance and produce a wide array of virulence factors, and its pivotal role in human infection, especially cystic fibrosis. It also provides an introduction to the strategies for treatment of both chronic and acute MRSA infections.

Original languageEnglish (US)
Pages (from-to)229-251
Number of pages23
JournalMethods in molecular biology (Clifton, N.J.)
Volume2069
DOIs
StatePublished - Jan 1 2020

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Infection
Community-Acquired Infections
Infectious Arthritis
Soft Tissue Infections
Virulence Factors
Osteomyelitis
Microbial Drug Resistance
Bacteremia
Cystic Fibrosis
Respiratory Tract Infections
Epidemiology
Skin

Keywords

  • Bacteremia
  • Community acquired
  • Hospital acquired
  • Lung infection
  • Methicillin-resistant Staphylococcus aureus

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options. / Chalmers, Sarah J.; Wylam, Mark.

In: Methods in molecular biology (Clifton, N.J.), Vol. 2069, 01.01.2020, p. 229-251.

Research output: Contribution to journalArticle

@article{4b9a709b2ed8410ab6dcb15ac7b22e6e,
title = "Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options",
abstract = "Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infection worldwide, including a wide array of both hospital- and community-acquired infections-most commonly bacteremia, upper and lower respiratory tract infection, skin and soft-tissue infection, osteomyelitis, and septic arthritis. This chapter describes the epidemiology of MRSA infection, its ability to confer antibiotic resistance and produce a wide array of virulence factors, and its pivotal role in human infection, especially cystic fibrosis. It also provides an introduction to the strategies for treatment of both chronic and acute MRSA infections.",
keywords = "Bacteremia, Community acquired, Hospital acquired, Lung infection, Methicillin-resistant Staphylococcus aureus",
author = "Chalmers, {Sarah J.} and Mark Wylam",
year = "2020",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-9849-4_16",
language = "English (US)",
volume = "2069",
pages = "229--251",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options

AU - Chalmers, Sarah J.

AU - Wylam, Mark

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infection worldwide, including a wide array of both hospital- and community-acquired infections-most commonly bacteremia, upper and lower respiratory tract infection, skin and soft-tissue infection, osteomyelitis, and septic arthritis. This chapter describes the epidemiology of MRSA infection, its ability to confer antibiotic resistance and produce a wide array of virulence factors, and its pivotal role in human infection, especially cystic fibrosis. It also provides an introduction to the strategies for treatment of both chronic and acute MRSA infections.

AB - Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infection worldwide, including a wide array of both hospital- and community-acquired infections-most commonly bacteremia, upper and lower respiratory tract infection, skin and soft-tissue infection, osteomyelitis, and septic arthritis. This chapter describes the epidemiology of MRSA infection, its ability to confer antibiotic resistance and produce a wide array of virulence factors, and its pivotal role in human infection, especially cystic fibrosis. It also provides an introduction to the strategies for treatment of both chronic and acute MRSA infections.

KW - Bacteremia

KW - Community acquired

KW - Hospital acquired

KW - Lung infection

KW - Methicillin-resistant Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=85072204202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072204202&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-9849-4_16

DO - 10.1007/978-1-4939-9849-4_16

M3 - Article

C2 - 31523777

AN - SCOPUS:85072204202

VL - 2069

SP - 229

EP - 251

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -